They are a blank check company. Their intent is to focus on opportunities in disruptive technologies and leverage the tremendous proprietary deal flow that their Board, executive team and sponsor, Chardan have developed over the past 17 years in the SPAC and investment banking marketplaces. Their focus on disruptive technologies is aligned to the investment expertise, relationships, proprietary deal flow, and connectivity of their management team, Board of Directors, and Chardan. Through their multiple decades of special purpose acquisition company, sector, direct investment, and investment banking advisory experiences, their sponsor and management team receive proprietary access to a tremendous pipeline of disruptive technology investment opportunities. As Chardan’s special purpose acquisition company advisory and principal special purpose acquisition company practices have expanded, their inbound deal flow in technology, among other sectors, has significantly increased as private companies seek out their proprietary expertise. Their pool of prospective target businesses are in the HealthTech and FinTech sectors.